1. The new progress in cancer immunotherapy

   • Ajmeri Sultana Shimu
   • Hua-xing Wei
   • Bofeng Li

   Review Article Open access 15 September 2022 Pages: 553 - 567

   

2. Immunotherapy for hepatocellular carcinoma

   • Mingzhen Zhou
   • Baorui Liu
   • Jie Shen

   Review Article 24 August 2022 Pages: 569 - 577

   

3. Anti-PD-1/PD-L1 immunotherapy in conversion treatment of locally advanced hepatocellular carcinoma

   • Jiaqi Chen
   • Ding Zhang
   • Ying Yuan

   Review Article 26 August 2022 Pages: 579 - 590

4. The immunomodulatory role of all-trans retinoic acid in tumor microenvironment

   • Guoshu Bi
   • Jiaqi Liang
   • Cheng Zhan

   Review Article 13 July 2022 Pages: 591 - 606

   

5. Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis

   • Francesco Prete
   • MariaTeresa Rotelli
   • Angela Gurrado

   Review Article Open access 01 August 2022 Pages: 607 - 617

   

6. Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies

   • Alla Kuznetsova
   • Olga Popova
   • Alexey Ivanov

   Review Article 09 September 2022 Pages: 619 - 643

   

7. Pathophysiology of deep vein thrombosis

   • Simón Navarrete
   • Carla Solar
   • Iván Palomo

   Review Article 26 April 2022 Pages: 645 - 654

   

8. Coagulopathy during COVID-19 infection: a brief review

   • Robin M. Cunningham
   • Kyle L. Johnson Moore
   • Jacen S. Moore

   Review Article 19 September 2022 Pages: 655 - 666

9. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome

   • Maria Angela Barletta
   • Gerardo Marino
   • Pietro Gatti

   Review Article 22 August 2022 Pages: 667 - 678

   

10. Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties

    • Hayder M. Al-kuraishy
    • Ali I. Al-Gareeb
    • Gaber El-Saber Batiha

    Review Article 24 May 2022 Pages: 679 - 688

    

11. Significant association between HIV infection and increased risk of COVID-19 mortality: a meta-analysis based on adjusted effect estimates

    • Xueya Han
    • Hongjie Hou
    • Yadong Wang

    Review Article 13 June 2022 Pages: 689 - 700

    

12. Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis

    • Lin Li
    • Xian Jiang
    • Yanyan Feng

    Review Article 30 April 2022 Pages: 701 - 715

    

13. Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuria

    • Bo Xu

    Review Article 19 April 2022 Pages: 717 - 726

14. Practical therapy for primary autoimmune hemolytic anemia in adults

    • Maria Celeste Fatone
    • Lorenzo Cirasino

    Review Article 18 August 2022 Pages: 727 - 736

15. MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases

    • Mohammad Reza Kalhori
    • Masoud Soleimani
    • Amir Ali Kalhori

    Review Article 08 July 2022 Pages: 737 - 750

    

16. A systematic review and meta-analysis of homocysteine concentrations in chronic obstructive pulmonary disease

    • Angelo Zinellu
    • Elisabetta Zinellu
    • Pietro Pirina

    Review Article Open access 05 May 2022 Pages: 751 - 758

    

17. Kidney function and renal resistive index in children with juvenile idiopathic arthritis

    • Alessandro Cafarotti
    • Maria Loredana Marcovecchio
    • Luciana Breda

    Review Article Open access 21 September 2022 Pages: 759 - 766

18. Plasma lipidome acts as diagnostic marker and predictor for cyclosporin response in patients with aplastic anemia

    • Jing Ruan
    • Chen Yang
    • Bing Han

    Original Article 21 April 2022 Pages: 767 - 776

    

19. ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-β1/SMAD3 signaling

    • Tianying Ren
    • Jing Wang
    • Dawei Yang

    Original Article 22 July 2022 Pages: 777 - 785

    

20. Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance

    • Lijuan Li
    • Shunjie Yu
    • Rong Fu

    Original Article 02 August 2022 Pages: 787 - 801

    

21. Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

    • Vincent Jachiet
    • Laure Ricard
    • MINHEMON: French Network of dysimmune disorders associated with hemopathies

    Original Article 11 August 2022 Pages: 803 - 813

    

22. Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma

    • Zhiluo Yang
    • Wei Yu

    Original Article 08 August 2022 Pages: 815 - 822

    

23. Correction to: Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B‑cell lymphoma

    • Zhiluo Yang
    • Wei Yu

    Correction 13 September 2022 Pages: 823 - 823

24. Effect of Lugol’s solution on ¹³¹I therapy efficacy in Graves’ disease

    • Jinyan Chai
    • Ruiguo Zhang
    • Renfei Wang

    Original Article 15 July 2022 Pages: 825 - 831

    

25. Papillary thyroid cancer with Hashimoto’s thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression

    • Su Jin Kim
    • Seung-Eun Lee
    • Eun Sook Kim

    Original Article Open access 24 July 2022 Pages: 833 - 840

    

26. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma

    • Yunus Sahin

    Original Article 09 July 2022 Pages: 841 - 851

    

27. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis

    • Hyun Chang
    • Sung Hyun Lee

    Original Article 23 June 2022 Pages: 853 - 858

    

28. Immunohistochemical expression of PD-L1 and MDR1 in breast tumors: association with clinico-pathological parameters and treatment outcome

    • Gisha Rose Antony
    • Paul Augustine
    • Lakshmi Subhadradevi

    Original Article 09 July 2022 Pages: 859 - 869

    

29. Ras suppressor-1 (RSU1) exerts a tumor suppressive role with prognostic significance in lung adenocarcinoma

    • Sofia Nikou
    • Marina Arbi
    • Vasiliki Bravou

    Original Article 21 June 2022 Pages: 871 - 885

    

30. The interaction of hsa_circ_0002594 and eIF4A3 promotes T-helper 2 cell differentiation by the regulation of PTEN

    • Jian Wang
    • Yuping Cheng

    Original Article 23 July 2022 Pages: 887 - 895

    

31. Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement

    • Francesco Iannazzo
    • Chiara Pellicano
    • Edoardo Rosato

    Original Article Open access 25 July 2022 Pages: 897 - 903

    

32. Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis

    • Dipanjan Bhattacharjee
    • Sumantro Mondal
    • Alakendu Ghosh

    Original Article 25 June 2022 Pages: 905 - 915

    

33. Anti-staphylococcal responses and their relationship with HLA-DR-DQ polymorphism in granulomatosis with polyangiitis: a preliminary evidence of association with disease outcome

    • Lekha Rani
    • Jagdeep Singh
    • Ranjana W. Minz

    Original Article 26 July 2022 Pages: 917 - 927

    

34. Gender dimorphism in IgA subclasses in T2-high asthma

    • Gilda Varricchi
    • Remo Poto
    • Giuseppe Spadaro

    Original Article Open access 25 April 2022 Pages: 929 - 941

    

35. Association of triglyceride–glucose index and the presence of low muscle mass in type 2 diabetes patients

    • Wenchao Hu
    • Yingqiang Ma
    • Dongming Xing

    Original Article 23 May 2022 Pages: 943 - 949

    

36. Autoimmunity in sarcoidosis: the tip of the Iceberg

    • Konstantinos I. Papadopoulos
    • Bengt Hallengren

    Letter to the Editor 17 August 2022 Pages: 951 - 953

37. Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”

    • Rujittika Mungmunpuntipantip
    • Viroj Wiwanitkit

    Letter to the Editor 02 September 2022 Pages: 955 - 955